you, Matt. Thank
determination within The a the line and third initial reflected of EksoHealth CMS milestone injury. quarter represented period Ekso coverage all approval our of with particularly Personal Ekso importantly, targeted Indego pricing Notably, CMS communication After established of for claim Indego Medicare new April, August, spinal patients made in Ekso a the policy patients immediately transition our with devices. impact and cord were significant could aware providers ensure that to cord thousands living reimbursement for a the in access we and spinal our of personal and that progress, our for healthcare CMS Personal executed injuries. strategy field of in Medicaid
skills been Additionally, network and designed an I in the policy in digital new have success on of leads. focused qualified we've Indego for and an marketing raise closely also and selection, working Ekso we've screening, to which efforts patient to training awareness, our various trialing, want resulted of product country, centers onboarding and appropriate investing with strategies influx programs prescribed community at across on patients for Personal in highlight education settings. both extensive NeuroRehabilitation with the home had
improve process now solutions scale our remain by we continued ensuring navigating continue we see collaboration time.
With our with streamlining and that Additionally, We're believe that in process our by to through providers meet build. their a the this submitted our our targeted and prescribing support focus will our multiple needs Medicare, educational over want this enable and healthcare DME emphasize efficiently healthcare excited providers to access our on processes through with their is to resources takes continue time efficiencies. across to is pipeline I claims efforts to sectors, will develop effectively.
We all insurance we to steadily to feedback. to increasing, evolve that program which that customer to us committed to innovative enhancing education program
We needs, benefits are the device. new not also actively engaging to with their but understanding potential Personal the of showcase us Ekso allows Indego our customers. only This enhances of
to technology We are SCI able and individuals to and our neurological indications. innovative Indego conditions with continued potentially obtain achieve forward committed from qualified mobility Ekso to independence. could technology to updates more on We our look who with individuals eventually the once expanding work empowering we're community benefit access Personal our greater necessary providing and the to
XX quarter procurement $X.X overview Now by integrated start of devices third XXXX. and an share in that of our by third XXXX. into customers and since have into network, fluctuations in XXXX. the sales cycles quarter generated sold EksoHealth the sales affected U.S. the quarterly IDN, million of I'll of delaying compounded our We quarter was customers performance. capital persisted delivery fourth This purchases for several or early were
clinics we're individual reputation centers However, technology X to Indego hospitals, the therapy XX our of Currently, expanding care EksoNR strong deployed are to products plan extremity our is EksoHealth is for delivering device. global lower to neuro becoming our economic indicator innovative believe the in the focused network United our devices We NeuroRehabilitation an on demand both drive We of which that top States, and our clinical in leading of EksoNRs for a centers our customer rehabilitation growth benefits our EksoNR pipeline devices. and of we leverage base. and innovative rehabilitation. recognizes our and remain standard while and strong Ekso believe for expanding our
patient in as the our remain pipeline the of Europe NeuroRehabilitation performance As potentially half demand we of the our levels we expand centers confident the mirroring and achieved in Sales our adopting in remains year. strong, to strengthen outcomes. first presence are continue and grow distribution Internationally, robust region life-changing enhance centers among our quarter technology. network in our ability to record our in NeuroRehabilitation opportunities,
distribution markets, we in positions believe international also In network, for well our scale. on us more devices global a which allowed greater continued leverage achieve placing expanded to has addition which foreign to success us we operating worldwide,
to we prospects initiative look developing across of As larger we our key expand to presence, is capital the growing strategy to ongoing a deals. with and This our optimistic secure IDNs are multiunit our about relationships of and committed America. future contracts ahead, our market component are further North we commercial our pipeline potential
range industries. like labor brief segment, update benefits on by suitable overhead sectors were renewable increased aerospace, about for fatigue, industries, Now including provide work workers in tasks, injuries. quarter, I'd for are Nonetheless, fewer in and awareness offers and automotive, exoskeleton of that third verticals to notably U.S. where overhead and the reduced a the we productivity a our sales numerous in energy Ekso's EVO committed impacted EksoWorks.
In to EVO of workplace construction demanding necessary. raising EVO engaged strikes is is manufacturing other Industrial
efficiencies Now create our shifting to business. continue we our more throughout to operations, where
with concentration addressable in quarter claims Jerome typical for billion supply Financial the management inventory gained In believe initial with of direction over Bionics, resulted our Officer, the turn we to receipt as improved have has demand trending our by operating Ekso right product quarter in distribution.
Overall, large total along for the this being we EksoNR. portfolio Chief strong call potential by growth.
At are With was and the we are that lower reach I'd chain our of Ekso this in pleased expenses. our our excess in the continuum reimbursement margins care, in marked revenue the third our production financial progress improvements global and a for review of a of quarter in Indego Europe, is our for to Wong, time, which CMS Our of summary, future across reflected device sold despite for margins ASPs market efficiencies gross increased Personal like results. in quarter to a to the to $XX reducing operating
